UNSPSC 51182032: Metandienone or methandrostenolone or methandienone

This classification denotes an anabolic steroid with the molecular formula C20H28O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier COZ1R7EOCC, chemically known as 17-beta-hydroxy-17-methyl-androsta-1,4-dien-3-one (9ci) but generally known as metandienone, which bears US NIH Compound Identifier 6300. European Medicines Agency schedules Metandienone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08812MIG. The term METANDIENONE is an International Non-Proprietary Name.

World Health Organization schedules metandienone in its Anatomical Therapeutic Chemical (ATC) Classification. METANDIENONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: OC1(C2(C(C3C(CC2)C2(C(=CC(=O)C=C2)CC3)C)CC1)C)C.

UNSPSC 51182032 Metandienone or methandrostenolone or methandienone is a Commodity code covering a synthetic anabolic steroid compound used in controlled pharmaceutical and research applications. State and local governments procure this substance primarily through health departments, correctional facilities, and university research institutions for legitimate medical and laboratory purposes where the compound is legally authorized. The code applies to pharmaceutical-grade metandienone in its various chemical forms and nomenclature variants, typically acquired as a raw material or finished pharmaceutical preparation subject to DEA scheduling and state pharmacy board oversight.

The source provides no recent state and local contract opportunities for this commodity code. Without posted solicitations, the degree of issuing-body participation, geographic distribution, and current market activity cannot be characterized. Procurement under this code, when it occurs, likely follows specialized procurement pathways tied to DEA licensing, pharmaceutical supplier networks, and controlled-substance chain-of-custody requirements rather than open competitive notices.